Creating new antiviral drugs: UMBC professor’s innovative “fleximer” research to receive $3.5M from NIH

Due to their flexibility, Katherine Seley-Radtke’s fleximers can be more effective against multiple similar viruses or a virus that has accumulated some mutations.